Five Prime Therapeutics Inc
Antibodies Binding to Vista at Acidic pH
Last updated:
Abstract:
The present application relates to antibodies specifically binding to the V-domain immunoglobulin-containing suppressor of T-cell activation (VISTA) at acidic pH and their use in cancer treatment. In some embodiments, the antibodies bind specifically to human VISTA at acidic pH, but do not significantly bind to human VISTA at neutral or physiological pH.
Status:
Application
Type:
Utility
Filling date:
10 Jul 2019
Issue date:
10 Mar 2022